Nykode Therapeutics Announces FDA Approval of IND for : vima

FDA approval of IND for VB-C-04 trial.Nykode to further elaborate on trial design and development strategy at upcoming capital markets day in New York on...

Related Keywords

Norway , Oslo , Agnete Fredriksen , Michael Engsig , Nykode Vaccibody , Genentech , Oslo Stock Exchange , Roche Group , New York , Capital Markets Day , Antigen Presenting Cells , Nykode Therapeutics , Business Officer , Oslo Stock Exchange Nykd , Ykode Therapeutics Asa ,